Loading company…
New Pulse Medicine develops stem cell, cell technology and gene diagnosis applications.
New Pulse Medicine develops human stem cell applications, cell technologies, and gene diagnosis and treatment tools. It also wholesales and retails Class I and II medical devices, working with medical institutions and consumers. Founded in 2024, the company is based in Beijing, China. In February 2026, it closed a pre-series A funding round.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in